T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Editas Medicine
EDIT
$432M
| $369K | ﹤0.01% |
49,704
+7,174
| +17% | +$59.6K |
|
|
ATSG
2327
DELISTED
Air Transport Services Group
ATSG
| $369K | ﹤0.01% |
26,766
+295
| +1% | +$4.25K |
|
2328
Heartland Express
HTLD
$979M
| $368K | ﹤0.01% |
30,780
+1,965
| +7% | +$25K |
|
2329
Janus International
JBI
$686M
| $368K | ﹤0.01% |
24,278
+2,799
| +13% | +$40.7K |
|
2330
Cerus
CERS
$572M
| $365K | ﹤0.01% |
192,873
+8,982
| +5% | +$18.3K |
|
|
REFI
2331
Chicago Atlantic Real Estate Finance
REFI
$264M
| $365K | ﹤0.01% |
23,105
+1,111
| +5% | +$17.8K |
|
2332
Alphatec Holdings
ATEC
$1.51B
| $364K | ﹤0.01% |
26,346
+3,268
| +14% | +$48.5K |
|
|
ETNB
2333
DELISTED
89bio
ETNB
| $364K | ﹤0.01% |
31,221
+7,000
| +29% | +$77.5K |
|
|
NTST
2334
NETSTREIT Corp
NTST
$2.09B
| $364K | ﹤0.01% |
19,780
+2,391
| +14% | +$42.3K |
|
2335
Quanex
NX
$981M
| $363K | ﹤0.01% |
9,440
+1,171
| +14% | +$39K |
|
|
PSTL
2336
Postal Realty Trust
PSTL
$701M
| $363K | ﹤0.01% |
25,305
+468
| +2% | +$6.63K |
|
2337
Veritone
VERI
$139M
| $361K | ﹤0.01% |
68,528
+1,996
| +3% | +$4.71K |
|
2338
RCI Hospitality Holdings
RICK
$230M
| $360K | ﹤0.01% |
6,204
+371
| +6% | +$21.8K |
|
|
MRSN
2339
DELISTED
Mersana Therapeutics
MRSN
| $359K | ﹤0.01% |
3,197
+198
| +7% | +$19.7K |
|
|
CVGW
2340
DELISTED
Calavo Growers
CVGW
| $357K | ﹤0.01% |
12,819
+582
| +5% | +$16.3K |
|
|
SAVE
2341
DELISTED
Spirit Airlines, Inc.
SAVE
| $357K | ﹤0.01% |
73,622
+3,955
| +6% | +$29.2K |
|
|
ZIMV
2342
DELISTED
ZimVie
ZIMV
| $356K | ﹤0.01% |
21,531
+1,275
| +6% | +$22.7K |
|
2343
James River Group Holdings
JRVR
$200M
| $355K | ﹤0.01% |
37,989
+9,414
| +33% | +$86.4K |
|
2344
State Street Technology Select Sector SPDR ETF
XLK
$125B
| $355K | ﹤0.01% |
3,400
| – | – |
|
|
TRST
2345
Trustco Bank Corp NY
TRST
$971M
| $354K | ﹤0.01% |
12,556
+662
| +6% | +$18.7K |
|
2346
Buckle
BKE
$2.31B
| $352K | ﹤0.01% |
8,734
+1,096
| +14% | +$43.1K |
|
|
DHC
2347
Diversified Healthcare Trust
DHC
$2.03B
| $352K | ﹤0.01% |
143,013
-28,169
| -16% | -$80.7K |
|
2348
Artesian Resources
ARTNA
$369M
| $351K | ﹤0.01% |
9,447
+382
| +4% | +$13.9K |
|
2349
Willdan Group
WLDN
$1.29B
| $351K | ﹤0.01% |
12,107
+493
| +4% | +$10.7K |
|
|
CMRC
2350
Commerce.com Inc Series 1
CMRC
$184M
| $350K | ﹤0.01% |
50,794
+3,188
| +7% | +$25.6K |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.